Search

Author/Creator Matveev, Vsevolod B

1. Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study. Issue 11 (November 2022)

Authors:
Merseburger, Axel S; Attard, Gerhardt; Åström, Lennart; Matveev, Vsevolod B; Bracarda, Sergio; Esen, Adil; Feyerabend, Susan; Senkus, Elżbieta; López-Brea Piqueras, Marta; Boysen, Gunther; Gourgioti, Georgia; Martins, Karla; Chowdhury, Simon
Journal:
Lancet oncology
Issue:
Volume 23:Issue 11(2022)
Page Start:
1398
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search